US 11,685,791 B2
Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membrane
Sunghoon Kim, Seoul (KR); Hyunbo Shim, Seoul (KR); Nam Hoon Kwon, Gyeonggi-do (KR); and Daeyoung Han, Gyeonggi-do (KR)
Assigned to Zymedi Co., Ltd., Incheon (KR)
Appl. No. 16/498,505
Filed by Zymedi Co., Ltd., Incheon (KR)
PCT Filed Mar. 27, 2018, PCT No. PCT/KR2018/003594
§ 371(c)(1), (2) Date Sep. 27, 2019,
PCT Pub. No. WO2018/182284, PCT Pub. Date Oct. 4, 2018.
Claims priority of application No. 10-2017-0038775 (KR), filed on Mar. 27, 2017; application No. 10-2017-0118890 (KR), filed on Sep. 15, 2017; and application No. 10-2017-0118917 (KR), filed on Sep. 15, 2017.
Prior Publication US 2020/0102402 A1, Apr. 2, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/40 (2006.01); C12N 15/52 (2006.01); G01N 33/574 (2006.01)
CPC C07K 16/40 (2013.01) [C12N 15/52 (2013.01); G01N 33/574 (2013.01)] 8 Claims
 
1. An antibody or fragment thereof specifically binding to an epitope consisting of a sequence of SEQ ID NO: 101, SEQ ID NO: 106, or SEQ ID NO: 111 in the lysyl-tRNA synthetase (KRS) N-terminus, wherein the antibody or fragment thereof specifically binds to an extracellularly exposed lysyl-tRNA synthetase (KRS) N-terminal region, wherein the antibody or fragment thereof comprises a heavy chain variable region and a light chain variable region which are selected from the group consisting of:
a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 1, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 3, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 5, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 7, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 9, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 11;
a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 13, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 15, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 17, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 19, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 21, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 23;
a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 25, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 27, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 29, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 31, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 33, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 35; and
a heavy chain variable region comprising heavy chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 37, heavy chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 39, and heavy chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 41, and a light chain variable region comprising light chain complementary determining region 1 containing the amino acid sequence defined by SEQ ID NO: 43, light chain complementary determining region 2 containing the amino acid sequence defined by SEQ ID NO: 45, and light chain complementary determining region 3 containing the amino acid sequence defined by SEQ ID NO: 47.